Yttrium-90 radioembolization as an in vivo immune modulator: clinical evidence and pharmacologic implications. [PDF]
Tang S, Cai J, Wu P, Wang G.
europepmc +1 more source
Correction: Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selection. [PDF]
Lüdemann WM +9 more
europepmc +1 more source
Radioembolization of hepatic tumors.
Unresectable primary and metastatic liver tumors are a leading cause of cancer mortality and morbidity. This remains a challenging and key task for every oncologist despite significant advances that have been made with selective targeted systemic agents and in technology advances with radiotherapy delivery.
openaire +1 more source
Muscle and fat matter: Automated CT-based body composition analysis predicts survival in <i>Hepatocellular carcinoma</i> patients undergoing radioembolization. [PDF]
Steinberg-Vorhoff HL +9 more
europepmc +1 more source
No More Detours: Hepatopulmonary Shunt Reduction in a Patient with Hepatocellular Carcinoma after Treatment with Bevacizumab. [PDF]
Jeschke M +8 more
europepmc +1 more source
Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial [PDF]
core +1 more source
Yttrium-90 radioembolization for primary and metastatic liver tumors exhibiting arterial-phase hypovascularity. [PDF]
Malavia M +8 more
europepmc +1 more source
Yttrium-90 microsphere induced gastrointestinal tract ulceration [PDF]
Christopher D South +7 more
core +1 more source
Hepatic embolization for Cushing syndrome from metastatic tumors: a single-center case series. [PDF]
Zhang S +9 more
europepmc +1 more source
Transarterial Radioembolization (TARE) Complicated by a Mycotic Aneurysm and Bleeding: A Case Presentation and Literature Review. [PDF]
Hu EH.
europepmc +1 more source

